Amiflamine
CAS No. 77502-96-6
Amiflamine( 4-(dimethylamino)-alpha,2-dimethylphenethylamine )
Catalog No. M22235 CAS No. 77502-96-6
Amiflamine is an inhibitor of reversible MAO-A.The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue; a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 797 | Get Quote |
|
| 10MG | 1071 | Get Quote |
|
| 25MG | 1602 | Get Quote |
|
| 50MG | 2187 | Get Quote |
|
| 100MG | 2952 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAmiflamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmiflamine is an inhibitor of reversible MAO-A.The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue; a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely.
-
DescriptionAmiflamine is an inhibitor of reversible MAO-A.The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue; a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely. Definite underestimation occurred with amiflamine in both tissues. Kinetic investigations using homogenates from pretreated rats showed amiflamine to be a competitive inhibitor; cimoxatone was competitive in the liver but showed a more complex pattern in the brain. Moclobemide was noncompetitive in both tissues, as has been shown previously for brofaremine. Moclobemide prevented the deamination of dopamine and serotonin released from their striatal stores by tetrabenazine nearly as efficiently as clorgyline at an otherwise equieffective dose; cimoxatone was somewhat less effective relative to the reference compound, as was brofaremine, which was however given at a more effective dose. Amiflamine was much less effective than clorgyline at protecting dopamine, but equieffective with respect to serotonin.Amiflamine was 3 times less potent within noradrenergic neurons than within serotonergic neurons. A brain to plasma ratio of about 20:1 was found for amiflamine and its metabolites. The plasma and the brain concentrations of the N-demethylated metabolite [FLA 788(+)] exceeded that of amiflamine after a single dose, whereas the N,N-demethylated [FLA 668(+)] was found in low concentrations. The effect on MAO-A correlated significantly with the plasma and the brain concentration of FLA 788(+).
-
In Vitro——
-
In Vivo——
-
Synonyms4-(dimethylamino)-alpha,2-dimethylphenethylamine
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorMAO-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number77502-96-6
-
Formula Weight192.3
-
Molecular FormulaC12H20N2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (130.01 mM)
-
SMILESc1(c(ccc(c1)N(C)C)[C@@H](N)CC)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Waldmeier P C . On the reversibility of reversible MAO inhibitors[J]. Naunyn-Schmiedeberg's archives of pharmacology, 1985, 329(3):305-10.
molnova catalog
related products
-
Linezolid
Linezolid is a synthetic antibiotic, the first of the oxazolidinone class.
-
PF-9601N
PF-9601N showed high potency and selectivity as a MAO-BI (monoamine oxidase type B inhibitor) and also demonstrated remarkable neuroprotective properties in several in vivo and cellular models of PD.
-
Pargyline hydrochlor...
Pargyline hydrochloride is an irreversible inhibitor of monoamine oxidase (MAO) that is used clinically to treat moderate hypertension.
Cart
sales@molnova.com